State of Wyoming’s Kiniksa Pharmaceuticals KNSA Stock Holding History

State of Wyoming’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$625K	Sell	12,976 -304	-2%	-$13.5K	0.07%	217
2025 Q4	$548K	Buy	13,280 +5,318	+67%	+$213K	0.06%	319
2025 Q3	$309K	Buy	+7,962	New	+$259K	0.04%	676
2025 Q2	–	Sell	-17,064	Closed	-$379K	–	1982
2025 Q1	$379K	Buy	17,064 +2,258	+15%	+$46.5K	0.05%	398
2024 Q4	$293K	Buy	+14,806	New	+$338K	0.04%	581
2024 Q3	–	Sell	-3,893	Closed	-$72.7K	–	1805
2024 Q2	$72.7K	Buy	+3,893	New	+$72.9K	0.01%	1213
2024 Q1	–	Sell	-2,342	Closed	-$41.1K	–	1736
2023 Q4	$41.1K	Buy	+2,342	New	+$38.5K	0.01%	1394
2023 Q2	–	Sell	-8,231	Closed	-$88.6K	–	1675
2023 Q1	$88.6K	Buy	8,231 +1,071	+15%	+$14.1K	0.03%	851
2022 Q4	$107K	Buy	7,160 +2,087	+41%	+$30.4K	0.04%	703
2022 Q3	$65K	Buy	+5,073	New	+$57.8K	0.03%	877
2022 Q1	–	Sell	-151	Closed	-$2K	–	1916
2021 Q4	$2K	Buy	+151	New	+$1.86K	﹤0.01%	1774
2021 Q3	–	Sell	-235	Closed	-$3K	–	1277
2021 Q2	$3K	Buy	+235	New	+$3.57K	﹤0.01%	1096

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State of Wyoming's KNSA Position: Q1 2026 in Review

State of Wyoming reduced its Kiniksa Pharmaceuticals (KNSA) stake by 2.3% in Q1 2026, selling an estimated $13.5K and leaving 12,976 shares worth $625K. The position accounts for 0.07% of the portfolio, ranked #217.

State of Wyoming first reported a position in KNSA in Q2 2021 and has held it in 12 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

State of Wyoming held 12,976 shares of Kiniksa Pharmaceuticals worth $625K as of Q1 2026.
State of Wyoming sold 304 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $13.5K.
Kiniksa Pharmaceuticals made up 0.07% of State of Wyoming's portfolio in Q1 2026, its #217 holding.
State of Wyoming first reported a position in Kiniksa Pharmaceuticals in Q2 2021 and has held it in 12 quarters since.
228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.